Your SlideShare is downloading. ×
  • Like
Presentation mvcc 2010_ver_april_15_2010_slide_share
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×

Now you can save presentations on your phone or tablet

Available for both IPhone and Android

Text the download link to your phone

Standard text messaging rates apply

Presentation mvcc 2010_ver_april_15_2010_slide_share

  • 350 views
Published

 

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
350
On SlideShare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
14
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Monterrey Venture Capital Conference
    ANGEL VENTURES MÉXICO, S.C.
    CLUB DE INVERSIONISTAS DE MÉXICO, A.C.
    BPS-CardiacMedicalDevicebyknavii.
  • 2. BPS-Cardiac: ThePain
    • People who needs CVBP (Central Venous Blood Pressure Measurement).
    Intensive Care Units (ICU)
    Heart attack
    Catheterization: Expensive & Risky, Procedure
    Potential Problems: Infections, Fluid shifts.
    Pain
    Val.
    Prop.
    Tech.
    Mkt.
    Opp.
    Bus.
    Mod.
    Team
    Fin.
    Status
  • 3. BPS-Cardiac: ValueProposition
    A painless, low cost, technology to measure CVBP.
    Stake Holder
    Patient and his Family
    Physician & Nurse
    Payers (Public & Private)
    Hospitals
    Government Regulator
    Value Created
    Lessen Pain and suffering
    Less en Lawsuitsfor wrong catheterizations.
    Reduce the currentCost of the procedure
    Increase the productivity (faciilities)
    Secure and effective treatments (Law/Reg.)
    Pain
    Val.
    Prop.
    Tech.
    Mkt.
    Opp.
    Bus.
    Mod.
    Team
    Fin.
    Status
  • 4. BPS-Cardiac: Technology
    A disruptive non-invasive technology that measure CVBP (Lab scale prototype is ready!!!!)
    Pain
    Val.
    Prop.
    Tech.
    Mkt.
    Opp.
    Bus.
    Mod.
    Team
    Fin.
    Status
  • 5. BPS-Cardiac: TechnologyCompetitiveness
    Pain
    Val.
    Prop.
    Tech.
    Mkt.
    Opp.
    Bus.
    Mod.
    Team
    Fin.
    Status
  • 6. BPS-Cardiac: MarketOpportunity
    PotentialMarket: US Market (ICU Beds)
    CAGR 12.3%
    Hospitals2
    2,754
    BPS-Cardicac:
    $4,000
    $491
    MUSD
    Beds in Hospitals2
    951,045
    Intensive Care Beds2
    122,810
    BCC Research Report Code HLC019D, Published: August 2009
    includes, equipment disposal and services.
    (2) American Hospital Association: Fast Facts on US Hospitals
    2009 report.
    Pain
    Val.
    Prop.
    Tech.
    Mkt.
    Opp.
    Bus.
    Mod.
    Team
    Fin.
    Status
  • 7. BPS-Cardiac: Business Model
    Goal: License the technology to a major Medical Device Manufacturer
    GE Medical Systems
    Johnson & Johnson Medical System
    Baxter
    Where We add value to the Business Model?
    Disruptive Technology
    Patent
    Exclusivity for US/Mexico Markets
    Regulatory Compliance
    Paperwork
    USPTO, FDA, COFEPRIS
    Clinical trials
    Manufacturing & Testing (1,000 Units)
    Pain
    Val.
    Prop.
    Tech.
    Mkt.
    Opp.
    Bus.
    Mod.
    Team
    Fin.
    Status
  • 8. BPS-Cardiac: TheTeam
    Fernando Huerta
    Marco Sanchez
    Viridiana Omana
    Michele Gonzalez
    Pain
    Val.
    Prop.
    Tech.
    Mkt.
    Opp.
    Bus.
    Mod.
    Team
    Fin.
    Status
  • 9. BPS-Cardiac: Financials (ValueCreation)
    Product
    Target Market US/Mex:
    Units Solds: 28,179
    Revenue: $112M usd
    Royalties: $13.5 M usd
    NPV @12%: Investors, Founders & MDM: $28.6M usd
    Investors: 4.0 M usd
    Founders: $9.4M usd
    Medical Device Manufacturer: 15.2M usd
    Payback:
    Investors & Founders: 3.9 years
    Device Manufacter: 1.2 years
    Pain
    Val.
    Prop.
    Tech.
    Mkt.
    Opp.
    Bus.
    Mod.
    Team
    Fin.
    Status
  • 10. BPS-Cardiac: Funds Required
    VC investment in Medical Devices Startups $719MUSD / Q4 2009
    $ 1.56 MUSD
    Equity: 30%
    Funds used for:
    a) Exclusivity (US/Mex)
    b) FDA/COFEPRIS Approvals
    c) USPTO filing
    d) Clinical Trials
    e) Manufacturer 1,000 units
    f) Due diligence for contracting MDM
    Exit: Selling IP to a major Medical
    Device Manufacturer.
    Pain
    Val.
    Prop.
    Tech.
    Mkt.
    Opp.
    Bus.
    Mod.
    Team
    Fin.
    Status
  • 11. BPS-Cardiac: Status
    Negotiation:
    Medical Dev. Manufacturer (MDM)
    Licensing contract signed
    MDM Ready for Sale.
    Manufacturing 1,000 Units
    Clinical Trials
    FDA/COFEPRIS Approvals
    Raise Funds: $1.56 MUSD
    IP Filing
    US/Mex
    Massive
    Commercialization
    Raising Capital
    $1.56 MUSD
    R&D
    Royalties
    2005 – 2009
    2010
    2011
    2012
    2013
    Pain
    Val.
    Prop.
    Tech.
    Mkt.
    Opp.
    Bus.
    Mod.
    Team
    Fin.
    Status
  • 12. BPS Cardiac: Remember!!!!!!
    This is an Excellent Opportunity to invest in a non-invasive low risk disruptive technology that saves people lives.
    Business Upsides: More applications, can be expanded worldwide and with a potential of developing a recurrent business disposals.
    That requires an investment of $1.56 MUSD used for key success activities. (IP Lawers and filing and device manufacturing)
    And creates an economic value of $28.6M USD.
  • 13. BPS-Cardiac: Thanks you!!!!
    Information:
    fhuertamty@gmail.com
    Mobile: +52 +81 1516-8469